Understanding how HIV-1 proteins move within infected cells

Function of HIV-1 Env cytoplasmic tail domain

NIH-funded research Ohio State University · NIH-11190319

This study is looking at how a part of the HIV virus moves around inside infected cells to find new ways to stop the virus from spreading, which could help develop better treatments for people living with HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionOhio State University NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project IDNIH-11190319 on NIH RePORTER

What this research studies

This research investigates the movement of the HIV-1 glycoprotein Env within infected cells to understand how it reaches sites where the virus buds and forms synapses. By studying the complex trafficking mechanisms of Env, the research aims to identify new targets for antiviral drug development, which is crucial in the ongoing fight against AIDS. The project utilizes a unique variant of the Env protein that has developed resistance to inhibitors, allowing researchers to explore its behavior in different cell types. This could lead to insights that enhance our ability to combat HIV-1 effectively.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV-1, particularly those who may benefit from new antiviral treatments.

Not a fit: Patients who are not infected with HIV-1 or those who have already achieved viral suppression may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antiviral therapies that more effectively target HIV-1.

How similar studies have performed: Previous research has shown promise in targeting viral proteins for antiviral development, indicating that this approach could yield significant results.

Where this research is happening

Columbus, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency SyndromeAcquired Immunodeficiency Syndrome
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.